WBI Investments’s ResMed RMD Stock Holding History

WBI Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$526K	Sell	2,341 -3,313	-59%	-$826K	0.15%	184
2025 Q4	$1.36M	Buy	5,654 +2,704	+92%	+$692K	0.36%	64
2025 Q3	$808K	Sell	2,950 -2,421	-45%	-$661K	0.21%	138
2025 Q2	$1.39M	Sell	5,371 -2,069	-28%	-$494K	0.36%	80
2025 Q1	$1.67M	Sell	7,440 -8,172	-52%	-$1.91M	0.44%	65
2024 Q4	$3.57M	Buy	15,612 +9,624	+161%	+$2.32M	0.89%	20
2024 Q3	$1.46M	Buy	+5,988	New	+$1.34M	0.35%	82
2014 Q3	–	Sell	-343,044	Closed	-$17.4M	–	213
2014 Q2	$17.4M	Buy	343,044 +8,053	+2%	+$399K	0.74%	43
2014 Q1	$15M	Buy	+334,991	New	+$15M	0.66%	46
2013 Q4	–	Sell	-205,185	Closed	-$10.8M	–	129
2013 Q3	$10.8M	Buy	+205,185	New	+$9.95M	0.52%	59

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WBI Investments's RMD Position: Q1 2026 in Review

WBI Investments reduced its ResMed (RMD) stake by 59% in Q1 2026, selling an estimated $826K and leaving 2,341 shares worth $526K. The position accounts for 0.15% of the portfolio, ranked #184.

WBI Investments first reported a position in RMD in Q3 2013 and has held it in 10 quarters since. The position peaked at $17.4M in Q2 2014. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

WBI Investments held 2,341 shares of ResMed worth $526K as of Q1 2026.
WBI Investments sold 3,313 ResMed shares in Q1 2026, an estimated $826K.
ResMed made up 0.15% of WBI Investments's portfolio in Q1 2026, its #184 holding.
WBI Investments first reported a position in ResMed in Q3 2013 and has held it in 10 quarters since.
WBI Investments's ResMed position peaked at $17.4M in Q2 2014.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.